Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2137573 | Leukemia Research | 2010 | 7 Pages |
Abstract
Those results support early onset of ESA in lower risk MDS, to better avoid the consequences of anemia. Early introduction of ESA may also delay the need for RBC transfusions, hypothetically by slowing the disease course, but prospective studies are required to further assess this point.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sophie Park, Charikleia Kelaidi, Rosa Sapena, Dominique Vassilieff, Odile Beyne-Rauzy, Valérie Coiteux, Norbert Vey, Christophe Ravoet, Stéphane Cheze, Christian Rose, Laurence Legros, Aspasia Stamatoullas, Martine Escoffre-Barbe, Agnès Guerci,